PT82975B - Processo de preparacao do antigenio peptidico imunogenico correspondente a proteina circunsporozoito do plasmodium vivax e de vacina contra a malaria - Google Patents

Processo de preparacao do antigenio peptidico imunogenico correspondente a proteina circunsporozoito do plasmodium vivax e de vacina contra a malaria

Info

Publication number
PT82975B
PT82975B PT82975A PT8297586A PT82975B PT 82975 B PT82975 B PT 82975B PT 82975 A PT82975 A PT 82975A PT 8297586 A PT8297586 A PT 8297586A PT 82975 B PT82975 B PT 82975B
Authority
PT
Portugal
Prior art keywords
protein
circumsporozoito
plasmodium vivax
pct
preparation process
Prior art date
Application number
PT82975A
Other languages
English (en)
Other versions
PT82975A (en
Original Assignee
Univ New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York filed Critical Univ New York
Publication of PT82975A publication Critical patent/PT82975A/pt
Publication of PT82975B publication Critical patent/PT82975B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT82975A 1985-07-12 1986-07-11 Processo de preparacao do antigenio peptidico imunogenico correspondente a proteina circunsporozoito do plasmodium vivax e de vacina contra a malaria PT82975B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75464585A 1985-07-09 1985-07-09

Publications (2)

Publication Number Publication Date
PT82975A PT82975A (en) 1986-08-01
PT82975B true PT82975B (pt) 1988-07-01

Family

ID=25035714

Family Applications (1)

Application Number Title Priority Date Filing Date
PT82975A PT82975B (pt) 1985-07-12 1986-07-11 Processo de preparacao do antigenio peptidico imunogenico correspondente a proteina circunsporozoito do plasmodium vivax e de vacina contra a malaria

Country Status (13)

Country Link
US (1) US5700906A (pt)
EP (1) EP0229829B1 (pt)
JP (1) JPS63500591A (pt)
AT (1) ATE118784T1 (pt)
AU (1) AU590599B2 (pt)
DE (1) DE3650242T2 (pt)
DK (1) DK124087A (pt)
ES (2) ES2002467A6 (pt)
IL (1) IL79277A0 (pt)
NZ (1) NZ216823A (pt)
PT (1) PT82975B (pt)
WO (1) WO1987000533A1 (pt)
ZA (1) ZA865235B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826957A (en) * 1985-07-12 1989-05-02 New York University Immunogenic recombinant yeast expression product and method for purifying it
US4693994A (en) * 1985-11-19 1987-09-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Protective synthetic peptide against malaria and encoding gene
IL85905A0 (en) * 1987-03-30 1988-09-30 Univ New York Immunogenic recombinant yeast expression product and method for purifying it
IT1226711B (it) * 1988-08-05 1991-02-05 Eniricerche Spa Antigeni sintetici utili per la diagnosi della malaria da plasmodium vivax.
US6333406B1 (en) 1988-08-12 2001-12-25 Joseph W. Inselburg Gene encoding protein antigens of Plasmodium falciparum and uses therefor
GB8819209D0 (en) * 1988-08-12 1988-09-14 Research Corp Ltd Polypeptide & dna encoding same
SE8904100D0 (sv) * 1989-12-05 1989-12-05 Astra Ab New analysis method
NZ233255A (en) * 1989-04-11 1993-02-25 Chiron Corp Plasmodium cs protein analogues lacking one or more of the repeat epitopes, and containing at least one nonrepeat flanking epitope
AU5649290A (en) * 1989-04-12 1990-11-05 New York University Dendritic polymer of multiple antigen peptide system useful as anti-malarial vaccine
WO1993011157A1 (en) * 1991-11-27 1993-06-10 The Council Of The Queensland Institute Of Medical Research MALARIAL VACCINE AND PEPTIDES COMPRISING HUMAN T-CELL EPITOPE OF CIRCUMSPOROZOITE PROTEIN OF $i(P.VIVAX)
US7083777B1 (en) * 1999-04-02 2006-08-01 The Brigham And Women's Hospital, Inc. Immunomodulating polymers
ES2202218T3 (es) * 1999-12-17 2004-04-01 Schott Glas Capsula fulminante activable inductivamente para sistemas de retencion de pasajeros y circuito de prueba para esta capsula fulminante.
SV2003000753A (es) 2000-12-05 2003-06-16 Brigham & Womens Hospital Uso de polisacaridos zwitterionicos para la especifica modulacion del progreso inmunologico
US20040176283A1 (en) * 2002-04-01 2004-09-09 Robinson John A. Methods and compositions for the design of synthetic vaccines
WO2004089407A2 (en) * 2003-03-31 2004-10-21 The Brigham And Women's Hospital, Inc. Zwitterionic immunomodulators for the treatment of asthma and allergy
TWI380996B (zh) 2004-09-17 2013-01-01 Hoffmann La Roche 抗ox40l抗體
US7749519B2 (en) * 2005-12-09 2010-07-06 Kim Lee Sim Unique DNA and polypeptide sequences based on the circumsporozoite protein of Plasmodium vivax
US8206726B2 (en) 2006-02-06 2012-06-26 The Brigham And Women's Hospital, Inc. Zwitterionic polysaccharides for promotion of immune system maturation and health
AU2007276217B2 (en) * 2006-07-18 2013-08-29 Glaxosmithkline Biologicals S.A. Vaccines for malaria
WO2013009945A1 (en) 2011-07-12 2013-01-17 The Brigham And Women's Hospital, Inc. Lipid-containing psa compositions, methods of isolation and methods of use thereof
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
US20140272993A1 (en) * 2013-03-15 2014-09-18 The Translational Genomics Research Institute Method of sequencing a full microrna profile from cerebrospinal fluid
CN108135167B (zh) 2015-08-19 2021-07-09 哈佛学院院长及董事 脂化psa组合物和方法
WO2018014012A1 (en) 2016-07-15 2018-01-18 President And Fellows Of Harvard College Glycolipid compositions and methods of use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2145092B (en) * 1983-01-28 1988-04-07 Univ New York Protective peptide antigen
US4466917A (en) * 1981-02-12 1984-08-21 New York University Malaria vaccine
US4559602A (en) * 1983-01-27 1985-12-17 Bates Jr John K Signal processing and synthesizing method and apparatus
US4769235A (en) * 1984-01-27 1988-09-06 New York University Immunodominant epitope of the circumsporozoite surface protein
AU584881B2 (en) * 1984-02-21 1989-06-08 British Technology Group Limited Improvements in or relating to the production of malaria vaccines
US4707357A (en) * 1984-06-26 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
ZA855232B (en) * 1984-07-23 1986-02-26 Univ New York Protective peptide antigen corresponding to plasmodium falciparum circumsporozoite protein
NZ213303A (en) * 1984-09-12 1988-09-29 Univ New York Plasmodium protein, dna sequence and vaccine
US4826957A (en) * 1985-07-12 1989-05-02 New York University Immunogenic recombinant yeast expression product and method for purifying it
US4693994A (en) * 1985-11-19 1987-09-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Protective synthetic peptide against malaria and encoding gene

Also Published As

Publication number Publication date
DE3650242D1 (de) 1995-03-30
DE3650242T2 (de) 1995-06-14
WO1987000533A1 (en) 1987-01-29
ZA865235B (en) 1987-03-25
ES2006631A6 (es) 1989-05-01
DK124087D0 (da) 1987-03-11
DK124087A (da) 1987-03-11
AU590599B2 (en) 1989-11-09
EP0229829A4 (en) 1988-07-27
EP0229829A1 (en) 1987-07-29
NZ216823A (en) 1990-12-21
JPS63500591A (ja) 1988-03-03
PT82975A (en) 1986-08-01
ES2002467A6 (es) 1988-08-16
IL79277A0 (en) 1986-09-30
EP0229829B1 (en) 1995-02-22
ATE118784T1 (de) 1995-03-15
US5700906A (en) 1997-12-23
AU6129286A (en) 1987-02-10

Similar Documents

Publication Publication Date Title
PT82975B (pt) Processo de preparacao do antigenio peptidico imunogenico correspondente a proteina circunsporozoito do plasmodium vivax e de vacina contra a malaria
CA2329772A1 (en) Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens
ES2100240T3 (es) Bacteriofagos modificados mediante ingenieria genetica y vacunas que los contienen.
WO1997030158A3 (fr) Proteine recombinante contenant un fragment c-terminal de msp-1 de plasmodium
ES8800273A1 (es) Perfeccionamientos en la fabricacion de conjugados de proteinas portadores de antigenos inmunogenicos para vacunas contra la malaria
IL75788A (en) Peptide comprising a repeated sequence of four amino acids,which sequence occurs in plasmodium falciparum circumsporozoite protein
CA2337754A1 (en) Recombinant multivalent malarial vaccine against plasmodium falciparum
NZ223174A (en) Peptides and multimers immunologically related to circumsporozoite protein; vaccines against plasmodium falciparum-induced malaria
DE3751670D1 (de) Coccidiosis-Impfstoff
KR920002629A (ko) B형 간염 코어 항원의 아미노산 잔기 서열
ATE159172T1 (de) Peptide und deren verwendung
NZ213303A (en) Plasmodium protein, dna sequence and vaccine
MY104081A (en) Rhoptry membrane antigen of plasmodium falciparum.
ATE237639T1 (de) Gegen die fläche von cryptosporidium-oozysten gerichteten igg1-klasse antikörper
Hockmeyer et al. Recent efforts in the development of a sporozoite vaccine against human malaria
IL94063A0 (en) Plasmodium circumsporozoite protein analogs lacking repeat sequences and their expression by recombinant methods
SE8702698L (sv) Polypeptid, anvendbar for framstellning av antimalariavacciner och diagnostest for pavisande av malariasjukdomar
EP0320034A3 (en) New immunologically active synthetic peptides useful for preparing an antimalarial vaccine
AU2609588A (en) Rhoptry antigen of plasmodium falciparum
Lal et al. Antisporozoite Malaria Vaccine Development Based on Circumsporozoite Protein
IE861786L (en) Immunogenic peptide antigen corresponding to plasmodium¹vivaz circumsporozoite protein
MY106940A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19950630